Neurological Outcomes After Pregnancy With Migraine Neurological Outcomes After Pregnancy With Migraine

Is maternal migraine associated with increased risks of adverse pregnancy outcomes in the mother, or adverse birth, neonatal or postnatal outcomes in the offspring?Headache
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Related Links:

ConclusionMigraines have a high incidence in gynaecology and obstetrics. Health care providers must include screening questions when history taking to identify women with migraines and effectively manage them. Proper follow-up and treatment is required for all women with migraines in order to minimize the risk of cerebrovascular events, and negative pregnancy outcomes. Women with migraines are advised to avoid combined hormonal contraception and use progesterone only pills.
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Neurology & Neurosurgery News Source Type: news
Morning sickness — the common term for nausea and vomiting during early pregnancy — is not unusual, as many women know. Starting around the sixth to eighth week of pregnancy, as many as 80% of women report having nausea and 50% experience vomiting. But as comedian Amy Schumer can attest, hyperemesis goes well beyond what people generally think of as morning sickness. Marked by doggedly persistent nausea and vomiting, hyperemesis occurs in up to three out of 100 pregnancies. Not surprisingly, women who have hyperemesis often lose weight: losing approximately 5% of pre-pregnancy weight is common. Why does hyperem...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Parenting Pregnancy Women's Health Source Type: blogs
TUESDAY, July 2, 2019 -- Pregnant women with migraine and their offspring have increased risks of several adverse pregnancy and neonatal outcomes, according to a study recently published in Headache. Nils Skajaa, from Aarhus University Hospital in...
Source: - Pharma News - Category: Pharmaceuticals Source Type: news
Abstract Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to t...
Source: Headache - Category: Neurology Authors: Tags: Headache Source Type: research
Abstract Migraine is a common headache disorder for which women are likely to seek care. This primary headache disorder, which often may be debilitating, has a higher prevalence in women than in men that is likely related to times of hormonal changes throughout the reproductive life cycle, such as menarche, pregnancy, postpartum period, lactation, perimenopause, and menopause, as well as to external hormonal changes associated with the use of oral contraceptives and hormone therapy. The obstetrician-gynecologist is well positioned to recognize and treat migraine and to recognize a potential relationship between es...
Source: Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Obstet Gynecol Source Type: research
(Aarhus University) Pregnant women with migraine have an increased risk of miscarriage, caesarean sections and giving birth to a child with low birth weight. This is shown by a comprehensive register-based study from Aarhus University and Aarhus University Hospital in Denmark. The study also suggests that prescription migraine drugs may alleviate the complications.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
(Reuters Health) - Pregnant women with migraine headaches are more likely to develop complications, and their babies are at higher risk for complications early after birth, too, a large study from Denmark suggests.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This study was performed to assess the safety of IDA and DA in a variety of endemic settings. Methods and findingsLarge community studies were conducted in five countries between October 2016 and November 2017. Two studies were performed in areas with no prior mass drug administration (MDA) for filariasis (Papua New Guinea and Indonesia), and three studies were performed in areas with persistent LF despite extensive prior MDA (India, Haiti, and Fiji). Participants were treated with a single oral dose of IDA (ivermectin, 200 μg/kg; diethylcarbamazine, 6 mg/kg; plus albendazole, a fixed dose of 400 mg) or with DA alone. T...
Source: PLoS Medicine - Category: Internal Medicine Authors: Source Type: research
Conclusion Correctly diagnosing PH and giving appropriate treatment is challenging. It is unclear whether active treatment with steroids improves clinical outcomes. The serious adverse effects of steroids are also taken into account. Observation, surgery and/or radiotherapy can be appropriate treatment modalities for selected patients. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: Experimental and Clinical Endocrinology and Diabetes - Category: Endocrinology Authors: Tags: Article Source Type: research
More News: Brain | Headache | Health | Migraine | Neurology | Neurosurgery | Perinatology & Neonatology | Pregnancy